Frontlight ResearchEarly access
CompletedPhase 4
TIMELAPSE study
Key facts
- Who runs it
- Ziekenhuis Gelderse Vallei Stichting
- Where
- Netherlands1 site in 1 countryChoose a country to see its sites
- Trial code
- EU 2024-518320-71-00
- EudraCT 2019-001520-35
- NL-OMON55662
- Status
- Completed
- Phase
- Phase 4
- People taking part
- 190 people enrolled
- Started
- 29 Oct 2024
- Ended
- 14 Jan 2026
- Type of study
- Interventional
- Record updated
- 29 October 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 27 criteriaShow less
Who can take part
- Adults aged 18 - 85 years visiting the outpatient clinic department of neurology
- Presence of insomnia disorder conform DSM-5, i.e. sleep problems in at least 3 nights a week, for at least 3 months with consequences for daytime functioning, the sleep problem cannot be better explained by or occurs exclusively during the course of another sleep disorder (e.g. sleep related breathing disorder, parasomnia)
- Score of 10 or more on the lnsomnia Severity lndex (lSl)
- Have a medical condition and/or chronic pain (> 3 months)
Who cannot take part
- Current alcohol or drug abuse or addiction (benzodiazepine excluded)
- Epilepsy
- Ocular Hypertension / Glaucoma
- Presence of a severe psychiatric disorder not in remission or adequately treated
- Allergy for amitriptyline
- Untreated sleep related breathing disorder
- Family history of acute cardiac death
- Recent myocardial infarction (within the past 90 days)
- Angina pectoris / coronary insufficiency
- A known diagnosis of dementia
- History of delirium
- Terminal illness (prognosis < 1 year)
- Cardiac arrhythmia / blockade / Long QT syndrome / Brugada syndrome
- Severe renal insufficiency (GFR <10) and/or severe liver dysfunction
- Habitual night shift worker
- Suicide risk
- Participation in other interventional medical scientific studies
- Current use of psychopharmaceuticals other than benzodiazepines
- Current use of antimycotica
- Wish to continue over-the-counter sleep aids as melatonin and medicinal cannabis
- Use of off-label amitriptyline for insomnia in the past year
- Being unable to follow study instructions and fill out the study questionnaires (in Dutch)
- Pregnancy, lactation or wish to become pregnant in the coming 6 months
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The main objective of the study is to determine whether low dose amitriptyline (10-20 mg) in chronic insomnia coexisting with medical conditions is as effective as CBT-I in improving subjective sleep.
Data and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Official title
- Efficacy of low dose amitriptyline vs. cognitive behavioural therapy for chronic insomnia and medical comorbidity: a randomized controlled non inferiority trial.
- Record updated
- 29 October 2024